<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25412261</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>11</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.</ArticleTitle><Pagination><StartPage>e3320</StartPage><MedlinePgn>e3320</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003320</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Interleukin (IL)-10 levels are increased in dengue virus (DENV)-infected patients with severe disorders. A hypothetical intrinsic pathway has been proposed for the IL-10 response during antibody-dependent enhancement (ADE) of DENV infection; however, the mechanisms of IL-10 regulation remain unclear.</AbstractText><AbstractText Label="PRINCIPLE FINDING" NlmCategory="RESULTS">We found that DENV infection and/or attachment was sufficient to induce increased expression of IL-10 and its downstream regulator suppressor of cytokine signaling 3 in human monocytic THP-1 cells and human peripheral blood monocytes. IL-10 production was controlled by activation of cyclic adenosine monophosphate response element-binding (CREB), primarily through protein kinase A (PKA)- and phosphoinositide 3-kinase (PI3K)/PKB-regulated pathways, with PKA activation acting upstream of PI3K/PKB. DENV infection also caused glycogen synthase kinase (GSK)-3&#x3b2; inactivation in a PKA/PI3K/PKB-regulated manner, and inhibition of GSK-3&#x3b2; significantly increased DENV-induced IL-10 production following CREB activation. Pharmacological inhibition of spleen tyrosine kinase (Syk) activity significantly decreased DENV-induced IL-10 production, whereas silencing Syk-associated C-type lectin domain family 5 member A caused a partial inhibition. ADE of DENV infection greatly increased IL-10 expression by enhancing Syk-regulated PI3K/PKB/GSK-3&#x3b2;/CREB signaling. We also found that viral load, but not serotype, affected the IL-10 response. Finally, modulation of IL-10 expression could affect DENV replication.</AbstractText><AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">These results demonstrate that, in monocytes, IL-10 production is regulated by ADE through both an extrinsic and an intrinsic pathway, all involving a Syk-regulated PI3K/PKB/GSK-3&#x3b2;/CREB pathway, and both of which impact viral replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Tsung-Ting</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yi-Jui</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Peng</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Sheng-Hsiang</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Microbiology and Immunology, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019067" MajorTopicYN="N">Antibody-Dependent Enhancement</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25412261</ArticleId><ArticleId IdType="pmc">PMC4239119</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0003320</ArticleId><ArticleId IdType="pii">PNTD-D-14-00851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Simmons CP, Farrar JJ, Nguyen v V, Wills B (2012) Dengue. N Engl J Med 366: 1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB (2012) Controversies in dengue pathogenesis. Paediatr Int Child Health 32 Suppl 15&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381449</ArticleId><ArticleId IdType="pubmed">22668442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lin CF, Yeh TM, Liu CC, Liu HS, et al. (2013) Autoimmunity in dengue pathogenesis. J Formos Med Assoc 112: 3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">23332423</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, et al. (2010) Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4: e699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879373</ArticleId><ArticleId IdType="pubmed">20532230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, et al. (2012) Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis 6: e1641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, et al. (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4: e785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919376</ArticleId><ArticleId IdType="pubmed">20706626</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh Hle A, et al. (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207: 1442&#x2013;1450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610419</ArticleId><ArticleId IdType="pubmed">22807519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, et al. (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55: 1216&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466094</ArticleId><ArticleId IdType="pubmed">22865871</ArticleId></ArticleIdList></Reference><Reference><Citation>Low JG, Sung C, Wijaya L, Wei Y, Rathore AP, et al. (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14: 706&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">24877997</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy BR, Whitehead SS (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">21219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ, Endy TP (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24: 442&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">21799408</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera R, Kuhn RJ (2008) Structural proteomics of dengue virus. Curr Opin Microbiol 11: 369&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2581888</ArticleId><ArticleId IdType="pubmed">18644250</ArticleId></ArticleIdList></Reference><Reference><Citation>Clyde K, Kyle JL, Harris E (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418&#x2013;11431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1642597</ArticleId><ArticleId IdType="pubmed">16928749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert IA, Wilschut J, Smit JM (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67: 2773&#x2013;2786.</Citation><ArticleIdList><ArticleId IdType="pubmed">20372965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, et al. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3: 866&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, et al. (2012) Endothelial cell surface expression of protein disulfide isomerase activates beta1 and beta3 integrins and facilitates dengue virus infection. J Cell Biochem 113: 1681&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">22422622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197: 823&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193896</ArticleId><ArticleId IdType="pubmed">12682107</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM (2005) Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79: 4557&#x2013;4567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069525</ArticleId><ArticleId IdType="pubmed">15795242</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3057165</ArticleId><ArticleId IdType="pubmed">20883967</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, et al. (2008) Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 197: 817&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">18269315</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Green S (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338: 67&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">19802579</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, et al. (2001) Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204: 494&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">11776403</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, et al. (2012) A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg 86: 341&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3269290</ArticleId><ArticleId IdType="pubmed">22302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">10865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59: 329&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">10502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, et al. (2012) Cellular and cytokine correlates of severe dengue infection. PLoS One 7: e50387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3510251</ArticleId><ArticleId IdType="pubmed">23209731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722886</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">15122797</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T, Kalayanarooj S, Ubol S (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88: 365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Halstead SB (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 17: 1829&#x2013;1835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008185</ArticleId><ArticleId IdType="pubmed">20876821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Phuklia W, Kalayanarooj S, Modhiran N (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201: 923&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">20158392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 4: 1169&#x2013;1176.</Citation><ArticleIdList><ArticleId IdType="pubmed">14639467</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, Jeewandara C, Alles KM, Salimi M, Gomes L, et al. (2013) Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl Trop Dis 7: e2409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3764236</ArticleId><ArticleId IdType="pubmed">24040431</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrentes-Carvalho A, Azeredo EL, Reis SR, Miranda AS, Gandini M, et al. (2009) Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz 104: 1091&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">20140369</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, et al. (2006) The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol 176: 2825&#x2013;2832.</Citation><ArticleIdList><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Tsai CC, Chen CL, Chen TY, Chen YP, et al. (2011) Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis. FASEB J 25: 3661&#x2013;3673.</Citation><ArticleIdList><ArticleId IdType="pubmed">21705667</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PC, Huang WC, Chen CL, Sheu BS, Shan YS, et al. (2012) Regulation of SHP2 by PTEN/AKT/GSK-3beta signaling facilitates IFN-gamma resistance in hyperproliferating gastric cancer. Immunobiology 217: 926&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pubmed">22325465</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772360</ArticleId><ArticleId IdType="pubmed">19822889</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">11483993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, et al. (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Tsai CC, Huang WC, Wang CY, Tseng HC, et al. (2008) IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J Cell Biochem 105: 746&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">18655171</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen AY, Sakamoto KM, Miller LS (2010) The role of the transcription factor CREB in immune function. J Immunol 185: 6413&#x2013;6419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519339</ArticleId><ArticleId IdType="pubmed">21084670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, Avvedimento EV (2001) cAMP signaling selectively influences Ras effectors pathways. Oncogene 20: 1186&#x2013;1192.</Citation><ArticleIdList><ArticleId IdType="pubmed">11313862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, et al. (1994) A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem 269: 32187&#x2013;32193.</Citation><ArticleIdList><ArticleId IdType="pubmed">7798217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, et al. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 97: 11960&#x2013;11965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17277</ArticleId><ArticleId IdType="pubmed">11035810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">8524413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CT, Chuang DM (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128: 281&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167234</ArticleId><ArticleId IdType="pubmed">20705090</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933525</ArticleId><ArticleId IdType="pubmed">16007092</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodgett JR, Ohashi PS (2005) GSK3: an in-Toll-erant protein kinase? Nat Immunol 6: 751&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">16034428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Pt 1): 15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1137648</ArticleId><ArticleId IdType="pubmed">8250835</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 21: 749&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">16543145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yost C, Torres M, Miller JR, Huang E, Kimelman D, et al. (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10: 1443&#x2013;1454.</Citation><ArticleIdList><ArticleId IdType="pubmed">8666229</ArticleId></ArticleIdList></Reference><Reference><Citation>Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, et al. (2012) The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12: 544&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572209</ArticleId><ArticleId IdType="pubmed">23084921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocsai A, Ruland J, Tybulewicz VL (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10: 387&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782221</ArticleId><ArticleId IdType="pubmed">20467426</ArticleId></ArticleIdList></Reference><Reference><Citation>Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771&#x2013;5777.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekker LG, Maartens G, Steyn L, Kaplan G (1998) Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis 178: 580&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">9697749</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 4123&#x2013;4132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034024</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, et al. (2007) Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 204: 979&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118571</ArticleId><ArticleId IdType="pubmed">17452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Kou Z, Zhang F, Yao X, Liu S, et al. (2010) Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One 5: e15631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012067</ArticleId><ArticleId IdType="pubmed">21206915</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">17525754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, et al. (2006) Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203: 2461&#x2013;2472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118120</ArticleId><ArticleId IdType="pubmed">17030951</ArticleId></ArticleIdList></Reference><Reference><Citation>Incrocci R, McCormack M, Swanson-Mungerson M (2013) Epstein-Barr Virus LMP2A Increases IL-10 production in mitogen-stimulated primary B cells and B cell lymphomas. J Gen Virol 10.1099/vir.0.049221-0..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3998239</ArticleId><ArticleId IdType="pubmed">23303827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, et al. (2001) Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis 184: 1268&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">11679915</ArticleId></ArticleIdList></Reference><Reference><Citation>Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, et al. (2002) HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 8: 562&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4656444</ArticleId><ArticleId IdType="pubmed">12046093</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154735</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddi H, Kumar R, Jain SK, Kumar V (2003) A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function. Virus Genes 26: 227&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">12876451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedadala GR, Palem JR, Graham L, Hill JM, McFerrin HE, et al. (2011) Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells. Virol J 8: 262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120787</ArticleId><ArticleId IdType="pubmed">21619646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer SI, Willars GB, Nishida E, Thiel G (2008) Elk-1, CREB, and MKP-1 regulate Egr-1 expression in gonadotropin-releasing hormone stimulated gonadotrophs. J Cell Biochem 105: 1267&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">18814180</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel G, Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">12384981</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai YT, Chang SY, Lee CN, Kao CL (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11: 604&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">19134117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhul Amin M, Mahbub AH, Sikder AR, Karim MM (2010) Prediction of the post-translational modification sites on dengue virus E protein and deciphering their role in pathogenesis. Int J Bioinform Res Appl 6: 508&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">21224207</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez GA, Montminy MR (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">2573431</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer CJ, Alenghat FJ, Rim P, Fong JH, Fabry B, et al. (2000) Mechanical control of cyclic AMP signalling and gene transcription through integrins. Nat Cell Biol 2: 666&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">10980709</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Cao Z, Chen J, Li R, Cao Y, et al. (2012) Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem 287: 11899&#x2013;11910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320938</ArticleId><ArticleId IdType="pubmed">22343630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282: 11613&#x2013;11617.</Citation><ArticleIdList><ArticleId IdType="pubmed">17329241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WL, Ho LJ, Chang DM, Chen CH, Lai JH (2009) Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39: 3413&#x2013;3422.</Citation><ArticleIdList><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064051</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai T (2005) Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25: 1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15742153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton O, Lambert SL, Krams SM, Martinez OM (2012) Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas. PLoS One 7: e42610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3411813</ArticleId><ArticleId IdType="pubmed">22880054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, et al. (2011) Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas. J Biol Chem 286: 37368&#x2013;37378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199484</ArticleId><ArticleId IdType="pubmed">21908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Moi ML, Lim CK, Takasaki T, Kurane I (2010) Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol 91: 103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">19776239</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhodapkar KM, Banerjee D, Connolly J, Kukreja A, Matayeva E, et al. (2007) Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med 204: 1359&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118610</ArticleId><ArticleId IdType="pubmed">17502666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KR, Ong EZ, Tan HC, Zhang SL, Zhang Q, et al. (2014) Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc Natl Acad Sci U S A 111: 2722&#x2013;2727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932915</ArticleId><ArticleId IdType="pubmed">24550301</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia E, Rosales C (2002) Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 72: 1092&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">12488490</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh KT, Son KH, Jung ID, Kang HK, Hwang SA, et al. (2012) Protein kinase C delta (PKCdelta)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia. J Biol Chem 287: 14226&#x2013;14233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340148</ArticleId><ArticleId IdType="pubmed">22393041</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E, Michalek SM, Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31: 24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2818223</ArticleId><ArticleId IdType="pubmed">19836308</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, et al. (2009) Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51: 853&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">19726098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama M, Hisatsune J, Yamasaki E, Isomoto H, Kurazono H, et al. (2009) Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem 284: 1612&#x2013;1619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615499</ArticleId><ArticleId IdType="pubmed">18996844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, et al. (2013) CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 121: 95&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">23152543</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA (2001) Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 75: 3501&#x2013;3508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114841</ArticleId><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>